Browse > Article
http://dx.doi.org/10.3904/kjim.2011.26.1.94

Successful Treatment of Stereotactic Body Radiation Therapy Combined with Transarterial Chemolipiodolization for Hepatocellular Carcinoma with Biliary Obstruction  

Park, Chan-Kwon (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
Bae, Si-Hyun (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
Yang, Hong-Jun (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
Chun, Ho-Jong (Department of Radiation Oncology, The Catholic University of Korea School of Medicine)
Choi, Il-Bong (Department of Radiation Oncology, The Catholic University of Korea School of Medicine)
Choi, Jong-Young (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
Yoon, Seung-Kew (Department of Internal Medicine, The Catholic University of Korea School of Medicine)
Publication Information
The Korean journal of internal medicine / v.26, no.1, 2011 , pp. 94-98 More about this Journal
Abstract
Conventional radiation therapy (RT) is a widely recognized treatment for hepatocellular carcinoma (HCC). However, conventional RT plays only a limited role in HCC treatment because of its low efficacy and the low tolerance of the liver for this modality. Stereotactic body radiation therapy (SBRT) was recently developed and represents the most advanced radiation therapy technique currently available. It can deliver a high dose in a short time to well-defined hepatic tumors, with rapid dose fall-off gradients. We believe that SBRT with transarterial chemolipiodolization (TACL) may prove promising as a combined treatment modality for HCC due to its precision and relative safety. Here we present a case of successful treatment of advanced HCC with obstructive jaundice using this combined modality.
Keywords
Hepatocellular carcinoma; Stereotactic body radiation therapy; Transarterial chemolipiodolization; Obstructive jaundice;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By SCOPUS : 0
연도 인용수 순위
1 Seong J, Keum KC, Han KH, et al. Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 1999;43:393-397.   DOI   ScienceOn
2 Han KH, Kim JK. Liver cancer in Korea. Hepatol Res 2007;37 Suppl 2:S106-S109.   DOI
3 Lau WY, Leung KL, Leung TW, et al. Obstructive jaundice secondary to hepatocellular carcinoma. Surg Oncol 1995;4:303-308.   DOI   ScienceOn
4 Mallory TB, Castleman B, Parris EE. Case records of the Massachusetts General Hospital Case. N Engl J Med 1947;237:673-678.   DOI
5 Lai EC, Lau WY. Hepatocellular carcinoma presenting with obstructive jaundice. ANZ J Surg 2006;76:631-636.   DOI   ScienceOn
6 Lau W, Leung K, Leung TW, et al. A logical approach to hepatocellular carcinoma presenting with jaundice. Ann Surg 1997;225:281-285.   DOI   ScienceOn
7 Yamada K, Izaki K, Sugimoto K, et al. Prospective trial of combined transcatheter arterial chemoembolization and threedimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2003;57:113-119.   DOI   ScienceOn
8 Seong J, Park HC, Han KH, et al. Clinical results of 3-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma in the cirrhotic patients. Hepatol Res 2003;27:30-35.   DOI   ScienceOn
9 You CR, Jang JW, Kang SH, et al. Efficacy of transarterial chemolipiodolization with or without 3-dimensional conformal radiotherapy for huge HCC with portal vein tumor thrombosis. Korean J Hepatol 2007;13:378-386.   DOI   ScienceOn
10 Lawrence TS, Ten Haken RK, Kessler ML, et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 1992;23:781-788.   DOI   ScienceOn
11 Blomgren H, Lax I, Goranson H, et al. Radiosurgery for tumors in the body: clinical experience using a new method. J Radiosurgery 1998;1:63-74.   DOI
12 Park HC, Seong J, Han KH, Chon CY, Moon YM, Suh CO. Doseresponse relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 2002;54:150-155.
13 Herfarth KK, Debus J, Lohr F, et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001;19:164-170.   DOI
14 Kwon JH, Bae SH, Kim JY, et al. Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer. BMC Cancer 2010;10:475-484.   DOI   ScienceOn